Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single center experience
This article is protected by copyright. All rights reserved.
Source: Journal of the European Academy of Dermatology and Venereology - Category: Dermatology Authors: Nora Woltsche,
Nadja Pichler,
Ingrid Wolf,
Nicola Di Meo,
Iris Zalaudek Tags: Letter to Editor Source Type: research
More News: Academies | Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Dermatology | Skin | Skin Cancer